Dermatology & Plastic Surgery Institute Outcomes
Surgical Quality Improvement
Dermatology & Plastic Surgery Institute Outcomes
Dermatology & Plastic Surgery Institute Surgery ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s Dermatology & Plastic Surgery Institute surgery ACS NSQIP performance benchmarked against 447 participating sites.
| Dermatology & Plastic Surgery (447 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidityᵃ | 362 | 8.29% | 5.31% |
| Pneumonia | 362 | 0.28% | 0.08% |
| Ventilator > 48 Hours | 362 | 0.00% | 0.01% |
| Renal Failure | 362 | 0.00% | 0.03% |
| Urinary Tract Infection (UTI) | 362 | 0.00% | 0.26% |
| Surgical Site Infection (SSI)ᵃ | 361 | 7.20% | 4.24% |
| Sepsis | 362 | 0.83% | 0.30% |
| Unplanned Reoperation | 362 | 6.08% | 5.01% |
| Unplanned Readmissionᵃ | 362 | 6.91% | 3.26% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.
